Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1.

IF 1.7 Q3 RHEUMATOLOGY
Open Access Rheumatology-Research and Reviews Pub Date : 2022-09-14 eCollection Date: 2022-01-01 DOI:10.2147/OARRR.S373589
Wesam Gouda, Aldosoky Abd Elaziz Alsaid, Awad Saad Abbas, Tarek M Abdel-Aziz, Mohamed Z Shoaeir, Abd Allah S Abd Elazem, Mohammad Hamdy Sayed
{"title":"Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1.","authors":"Wesam Gouda,&nbsp;Aldosoky Abd Elaziz Alsaid,&nbsp;Awad Saad Abbas,&nbsp;Tarek M Abdel-Aziz,&nbsp;Mohamed Z Shoaeir,&nbsp;Abd Allah S Abd Elazem,&nbsp;Mohammad Hamdy Sayed","doi":"10.2147/OARRR.S373589","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Lupus nephritis (LN) affects almost half of all individuals with systemic lupus erythematosus (SLE). Overt LN (OLN) symptoms might vary from asymptomatic microscopic hematuria to renal failure. However, when there are no clinical or laboratory indicators of renal involvement, some people with silent LN (SLN) may have pathological evidence of renal involvement identified by renal biopsy. Monocyte Chemotactic Protein 1 (MCP-1) is a chemotactic factor that promotes leukocyte migration to the kidney. MCP-1 urine levels (uMCP-1) have been demonstrated to be high in individuals with active LN. The purpose of this study was to discover the occurrence of SLN, as well as the possible variations between overt LN (OLN) and SLN across SLE patients based on the histopathological assessment, as well as the role of uMCP-1 in the early detection of SLN.</p><p><strong>Methods: </strong>An overall of 144 patients with SLE were included in the current research. Patients were subsequently divided into two groups: individuals who did not have clinical evidence of LN (84 patients) and those with OLN (60 patients). All the patients were subjected to the following investigations: uMCP-1, erythrocyte sedimentation rate (ESR), complement C3 (C3), complement C4 (C4), creatinine, albumin/creatinine ratio (uACR), creatinine clearance, quantitative assessment of proteinuria by 24-hour urine proteinuria (24hr UP) and percutaneous renal biopsy.</p><p><strong>Results: </strong>Sixty patients from group I (71.4%) showed glomerular lesions on renal biopsy (SLN), and class II was the predominant class. uMCP-1 had a sensitivity of 95.2% and a specificity of 98% in the detection of SLN, and uMCP-1 values were markedly higher in patients with OLN in comparison to SLN.</p><p><strong>Conclusion: </strong>The actual frequency of SLN may be higher than expected. High levels of uMCP-1 may have warranted the early activity of LN. uMCP-1 can be used as a non-invasive, useful tool for the prediction of LN.</p>","PeriodicalId":45545,"journal":{"name":"Open Access Rheumatology-Research and Reviews","volume":" ","pages":"161-170"},"PeriodicalIF":1.7000,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6f/b0/oarrr-14-161.PMC9482965.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Rheumatology-Research and Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OARRR.S373589","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: Lupus nephritis (LN) affects almost half of all individuals with systemic lupus erythematosus (SLE). Overt LN (OLN) symptoms might vary from asymptomatic microscopic hematuria to renal failure. However, when there are no clinical or laboratory indicators of renal involvement, some people with silent LN (SLN) may have pathological evidence of renal involvement identified by renal biopsy. Monocyte Chemotactic Protein 1 (MCP-1) is a chemotactic factor that promotes leukocyte migration to the kidney. MCP-1 urine levels (uMCP-1) have been demonstrated to be high in individuals with active LN. The purpose of this study was to discover the occurrence of SLN, as well as the possible variations between overt LN (OLN) and SLN across SLE patients based on the histopathological assessment, as well as the role of uMCP-1 in the early detection of SLN.

Methods: An overall of 144 patients with SLE were included in the current research. Patients were subsequently divided into two groups: individuals who did not have clinical evidence of LN (84 patients) and those with OLN (60 patients). All the patients were subjected to the following investigations: uMCP-1, erythrocyte sedimentation rate (ESR), complement C3 (C3), complement C4 (C4), creatinine, albumin/creatinine ratio (uACR), creatinine clearance, quantitative assessment of proteinuria by 24-hour urine proteinuria (24hr UP) and percutaneous renal biopsy.

Results: Sixty patients from group I (71.4%) showed glomerular lesions on renal biopsy (SLN), and class II was the predominant class. uMCP-1 had a sensitivity of 95.2% and a specificity of 98% in the detection of SLN, and uMCP-1 values were markedly higher in patients with OLN in comparison to SLN.

Conclusion: The actual frequency of SLN may be higher than expected. High levels of uMCP-1 may have warranted the early activity of LN. uMCP-1 can be used as a non-invasive, useful tool for the prediction of LN.

Abstract Image

Abstract Image

沉默型狼疮性肾炎:肾脏组织病理学特征和尿单核细胞趋化蛋白1的早期检测。
目的:狼疮性肾炎(LN)影响几乎一半的系统性红斑狼疮(SLE)患者。显性LN (OLN)症状可能从无症状的显微镜下血尿到肾功能衰竭不等。然而,当没有肾脏受累的临床或实验室指标时,一些无症状LN (SLN)患者可能有肾活检确定的肾脏受累的病理证据。单核细胞趋化蛋白1 (MCP-1)是一种促进白细胞向肾脏迁移的趋化因子。MCP-1尿水平(uMCP-1)已被证明在活动性LN患者中较高。本研究的目的是通过组织病理学评估,发现SLE患者SLN的发生情况,以及显性LN (OLN)和SLN之间可能存在的差异,以及uMCP-1在SLN早期发现中的作用。方法:本研究共纳入144例SLE患者。随后将患者分为两组:没有LN临床证据的患者(84例)和有LN的患者(60例)。所有患者均接受以下检查:uMCP-1、红细胞沉降率(ESR)、补体C3 (C3)、补体C4 (C4)、肌酐、白蛋白/肌酐比值(uACR)、肌酐清除率、24小时尿蛋白(24hr UP)定量评估蛋白尿及经皮肾活检。结果:I组60例(71.4%)患者在肾活检(SLN)中出现肾小球病变,以II类为主。uMCP-1检测SLN的敏感性为95.2%,特异性为98%,OLN患者的uMCP-1值明显高于SLN患者。结论:SLN的实际发生频率可能高于预期。高水平的uMCP-1可能保证了LN的早期活动。uMCP-1可作为一种无创、有用的预测LN的工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
0.00%
发文量
34
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信